Projects per year
Personal profile
Biography
Member: Monash RNA expert group.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Next-generation mRNA manufacturing and analysis technologies
Al-Wassiti, H. (Primary Chief Investigator (PCI))
Australian Research Council (ARC), Monash University – Internal School Contribution, Seqirus (Australia) Pty Ltd
11/06/24 → 10/06/27
Project: Research
-
Development of novel mRNA products for clinical trials
Pouton, C., Beilharz, T., Carroll, J., Porter, C., Al-Wassiti, H., Davidovich, C., Johnston, A. & Trevaskis, N.
10/05/23 → 2/10/28
Project: Research
-
RaRtech: a novel and rapid mRNA manufacturing technology for pandemics preparedness and therapeutics
Al-Wassiti, H., Pouton, C., Ho, J. & Teo, S.
mRNA Victoria, Monash University – Internal Faculty Contribution
21/10/22 → 20/01/25
Project: Research
-
Designing non-viral gene delivery system based on adenovirus core
31/03/16 → 1/04/18
Project: Research
-
Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles
He, X., Payne, T. J., Takanashi, A., Fang, Y., Kerai, S. D., Morrow, J. P., Al-Wassiti, H., Pouton, C. W. & Kempe, K., 25 Jun 2024, In: Biomacromolecules. 25, 7, p. 4591–4603 13 p.Research output: Contribution to journal › Article › Research › peer-review
7 Citations (Scopus) -
Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection
Takanashi, A., Pouton, C. W. & Al-Wassiti, H., 7 Aug 2023, In: Molecular Pharmaceutics. 20, 8, p. 3876-3885 10 p.Research output: Contribution to journal › Article › Research › peer-review
10 Citations (Scopus) -
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Nolan, T. M., Deliyannis, G., Griffith, M., Braat, S., Allen, L. F., Audsley, J., Chung, A. W., Ciula, M., Gherardin, N. A., Giles, M. L., Gordon, T. P., Grimley, S. L., Horng, L., Jackson, D. C., Juno, J. A., Kedzierska, K., Kent, S. J., Lewin, S. R., Littlejohn, M. & McQuilten, H. A. & 24 others, , Dec 2023, In: EBioMedicine. 98, 17 p., 104878.Research output: Contribution to journal › Article › Research › peer-review
Open Access9 Citations (Scopus) -
mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Al-Wassiti, H., Fabb, S. A., Grimley, S. L., Panakkal Kochappan, R., Ho, J., Wong, C. Y., Tan, C. W., Payne, T. J., Takanashi, A., Sicilia, H., Teo, S., McAuley, J. L., Ellenberg, P., Cooney, J. P., Davidson, K., Bowen, R. A., Pellegrini, M., Rockman, S., Godfrey, D. I. & Nolan, T. M. & 4 others, , 4 Oct 2023, 35 p. bioRxiv.Research output: Other contribution › Research
Open Access -
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections
You, H., Jones, M. K., Gordon, C. A., Arganda, A. E., Cai, P., Al-Wassiti, H., Pouton, C. W. & McManus, D. P., Mar 2023, In: Clinical Microbiology Reviews. 36, 1, p. 1-28 28 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access18 Citations (Scopus)
Press/Media
-
Here’s how pharmacies could boost Australia’s COVID vaccine rollout
11/06/21
1 Media contribution
Press/Media: Expert Comment
-
The mRNA revolution: How COVID-19 hit fast-forward on an experimental technology
22/04/21
1 Media contribution
Press/Media: Article/Feature
-
Shot in the arm: All you need to know about the COVID-19 vaccines, and their rollout
1/04/21
1 item of Media coverage
Press/Media: Expert Comment
-
4 things about mRNA COVID vaccines researchers still want to find out
5/02/21
1 Media contribution
Press/Media: Expert Comment
-
Scientists and government pushing for ways to make mRNA vaccines here
3/02/21
1 Media contribution
Press/Media: Article/Feature